Literature DB >> 19167765

Creation of a functional tricuspid valve: novel use of percutaneously implanted valve in right atrial to right ventricular conduit in a patient with tricuspid atresia.

David Tanous, Syed Najaf Nadeem, Xenos Mason, Jack M Colman, Lee N Benson, Eric M Horlick.   

Abstract

We report the first use of a stented pulmonic valve within the right atrial to right ventricular conduit of a patient who underwent a Björk modification Fontan for tricuspid atresia. In effect, a functional tricuspid valve was created. This case report demonstrates the feasibility of transcatheter valve replacement in positions other than the pulmonic or aortic valve and that future revision of conduits in the Björk modification Fontan can be performed percutaneously.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19167765     DOI: 10.1016/j.ijcard.2008.12.034

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Transcatheter Advances in the Treatment of Adult and Congenital Valvular Heart Disease.

Authors:  Jayendrakumar S Patel; Samir R Kapadia; Lourdes Prieto; E Murat Tuzcu; Amar Krishnaswamy
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-11

Review 2.  Percutaneous tricuspid valve implantation in failing bioprosthesis.

Authors:  Andreas Eicken; Peter Ewert
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

3.  Percutaneous pulmonary and tricuspid valve implantations: An update.

Authors:  Robert Wagner; Ingo Daehnert; Philipp Lurz
Journal:  World J Cardiol       Date:  2015-04-26

4.  Percutaneous transjugular implantation of MELODY® valve into tricuspid bioprosthesis.

Authors:  Castigliano M Bhamidipati; D Scott Lim; Michael Ragosta; Gorav Ailawadi
Journal:  J Card Surg       Date:  2013-06-17       Impact factor: 1.620

Review 5.  Impact of Right-Sided-Catheter-Based Valve Implantation on Decision-Making in Congenital Heart Disease.

Authors:  Joanna Ghobrial; Jamil Aboulhosn
Journal:  Curr Cardiol Rep       Date:  2016-04       Impact factor: 2.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.